Skip to content

Development of a novel deprescribing protocol focused on improving patient proactiveness

Development of a novel deprescribing protocol focused on improving patient proactiveness - Development of a novel deprescribing protocol focused on improving patient proactiveness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000047912
Enrollment
200
Registered
2022-06-01
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polypharmacy

Interventions

None listed

Sponsors

St. Mariannna University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) 65 years of age or older 2) A history of visits to the relevant medical institution within 6 months 3) Able to communicate in Japanese and have written consent to participate in the study 4) Prescription drug information from either a medication diary, medical record information, or receipt data that confirms at least 5 regular medications that have been ongoing for at least 4 weeks

Exclusion criteria

Exclusion criteria: 1) Has a diagnosis of dementia 2) Has a history of hospitalization with a change of prescription within 30 days 3) Any other person deemed inappropriate by the principal investigator

Design outcomes

Primary

MeasureTime frame
Self-reported hospitalizations, emergency department visits, and falls in the past 12 months

Countries

Japan

Contacts

Public ContactReiko Machino

St. Mariannna University School of Medicine Department of General Internal Medicine

tama-soushinnaika-002@marianna-u.ac.jp044-933-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026